Medicalg

Medicalg

MDG · WAR · Healthcare / Medical Devices

22.20PLN-0.25 (-1.11%)

Price History

Full chart

Market Stats

Previous Close22.45
Open22.50
Day Range21.95 – 23.25
52-Week Range23.90 – 38.65
Volume44.35K
Market Cap250.81M
P/E (TTM)0.00
Forward P/E714.29
EPS-0.70
Dividend Yield0.00%
Beta0.63
50-Day Avg26.61
200-Day Avg28.97

About

Medicalgorithmics S.A. provides AI-powered and noninvasive solutions for cardiac diagnostic in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythmAI, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices. The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. In addition, the company engages in research and development services, including algorithm development, clinical studies, software development, consulting services, and medical hardware development; and end-to-end ECG Monitoring for clinical trials. Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Krzysztof Siemionow M.D., Ph.D.
  • Employees109
  • HeadquartersCentral Tower Building, Warsaw, Poland, 02-001, Poland
  • Websitehttps://www.medicalgorithmics.pl

Leadership

  • Dr. Krzysztof Siemionow M.D., Ph.D.President of the Management Board & CEO
  • Mr. Michal ZaporaCFO & Member of the Management Board
  • Mr. Jaroslaw JerzakowskiChief Operating Officer
  • Mr. Przemyslaw TadlaChief Technology Officer
  • Ms. Linda S JohnsonChief Scientific Officer
  • Ms. Catalina Barrero GuzmanMarketing Manager

Financials

Income Statement

Currency: PLN2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.11M5.80M10.96M15.70M29.71M49.33M127.92M203.35M199.40M173.87M111.73M48.35M62.72M43.10M24.00M30.98M
Growth (%)-+41.33%+88.83%+43.20%+89.29%+66.02%+159.31%+58.97%-1.94%-12.81%-35.74%-56.73%+29.72%-31.28%-44.31%+29.09%
Cost of Revenue730.63K392.94K821.67K697.20K7.25M5.18M3.33M6.25M9.09M8.30M8.54M7.39M12.35M26.14M3.63M36.55M
Gross Profit3.38M5.41M10.14M15.00M22.46M44.15M124.59M197.10M190.32M165.57M103.19M113.17M50.37M16.95M20.37M-5.56M
Gross Margin82.21%93.23%92.50%95.56%75.60%89.49%97.40%96.93%95.44%95.22%92.36%234.07%80.30%39.34%84.86%-17.95%
Operating Expense1.26M2.32M3.07M4.99M8.57M23.02M78.06M155.28M165.59M165.71M140.70M117.57M33.15M16.52M36.91M5.91M
Operating Income2.12M3.09M7.07M10.01M13.89M21.13M46.53M41.82M24.72M-146.00K-37.51M-4.40M17.21M433.00K-16.54M-11.47M
Operating Margin51.53%53.19%64.51%63.74%46.75%42.83%36.37%20.57%12.40%-0.08%-33.57%-9.10%27.44%1.00%-68.90%-37.02%
EBITDA2.26M3.71M9.71M13.95M18.61M18.92M52.49M53.55M37.02M18.38M-23.04M-2.20M29.75M2.23M-11.98M-6.83M
EBITDA Margin55.00%63.93%88.56%88.89%62.62%38.36%41.03%26.33%18.56%10.57%-20.62%-4.56%47.44%5.19%-49.91%-22.04%
Net Income1.91M3.01M7.44M10.87M14.53M13.93M40.11M25.54M14.42M-299.00K-12.92M-180.64M-11.86M-578.00K-16.08M-11.68M
Net Income Margin46.50%51.78%67.86%69.27%48.89%28.23%31.35%12.56%7.23%-0.17%-11.56%-373.61%-18.91%-1.34%-67.00%-37.71%
R&D--415.80K418.80K420.90K1.19M1.37M716.00K455.00K1.25M1.35M2.59M2.59M936.00K--
R&D as % of Total Revenue--3.79%2.67%1.42%2.41%1.07%0.35%0.23%0.72%1.21%5.36%4.13%2.17%--
Interest Expense15.11K6.02K100.13K8003.00K23.50K3.29M4.49M3.86M2.31M1.02M620.00K271.00K108.00K163.00K2.05M
Interest Expense % of Total Revenue0.37%0.10%0.91%0.01%0.01%0.05%2.57%2.21%1.94%1.33%0.91%1.28%0.43%0.25%0.68%6.61%

Balance Sheet

Currency: PLN2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.68M13.45M75.58M83.51M94.89M102.27M369.89M289.28M316.08M283.26M283.40M114.41M108.74M121.63M105.81M111.10M
Total Liabilities845.70K1.57M1.76M2.58M4.10M3.08M154.94M85.55M85.32M58.54M76.04M67.02M28.66M29.07M28.63M46.46M
Total Equity2.83M11.88M73.82M80.93M90.79M99.19M176.97M168.91M189.86M195.84M207.35M47.38M94.67M92.56M77.17M64.62M
Cash--58.45M38.41M24.20M19.96M47.54M32.53M60.19M11.15M16.20M11.67M26.16M25.50M5.50M2.73M
Total Debt--839.5831.40K2.70K30.70K77.36M72.55M66.20M40.31M39.38M9.64M9.00K5.69M4.13M22.56M
Net Debt---58.45M-38.37M-24.20M-19.93M2.60M26.17M6.02M29.16M23.18M-2.02M-26.16M-19.81M-1.37M19.83M

Cash Flow

Currency: PLN2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.67M2.69M4.11M5.58M-2.91M17.35M35.48M28.61M44.23M13.50M-3.96M-6.48M6.33M182.00K-13.08M-1.82M
Investing Cash Flow21.57K-3.60M-6.96M-21.89M-6.64M-16.06M-80.70M-22.03M2.41M-2.79M-5.00M-15.78M-1.81M1.96M-7.37M-13.79M
Financing Cash Flow-290.84K6.04M54.50M-3.73M-4.66M-5.53M72.80M-21.59M-18.98M-59.74M14.01M17.73M9.98M-2.81M447.00K12.83M
Capital Expenditure0933.56K205.84K229.00K5.16M2.69M8.49M37.83M6.43M8.74M5.00M15.88M12.37M11.32M9.97M314.00K
Free Cash Flow1.67M1.76M3.91M5.35M-8.07M14.65M26.99M-9.22M37.80M4.75M-8.96M-22.36M-6.04M-11.14M-23.05M-2.14M
Dividends Paid---3.76M4.66M5.53M6.39M11.56M5.12M-------
FCF to OCF100.00%65.28%95.00%95.89%277.48%84.47%76.07%-32.23%85.46%35.22%226.52%345.08%-95.45%-6119.23%176.21%117.23%
Dividend Paid to FCF---70.39%-57.82%37.73%23.68%-125.43%13.55%-------

Earnings

Report DateDec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Sep 17, 2014Nov 14, 2014Mar 20, 2015Jun 3, 2015Sep 1, 2015Nov 13, 2015Mar 11, 2016May 16, 2016Aug 31, 2016Nov 14, 2016Mar 30, 2017May 22, 2017Aug 31, 2017Nov 22, 2017Mar 21, 2018May 22, 2018Aug 28, 2018Nov 20, 2018Mar 26, 2019May 28, 2019Sep 3, 2019Nov 26, 2019Dec 31, 2019Apr 29, 2020Sep 1, 2020Nov 24, 2020Mar 30, 2021May 25, 2021Sep 30, 2021Nov 15, 2021Dec 31, 2021Apr 28, 2022Sep 30, 2022Dec 31, 2022May 30, 2023Sep 28, 2023Nov 29, 2023Dec 31, 2023May 29, 2024Sep 30, 2024Nov 29, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate----------1.151.531.792.211.121.180.81----------------------------------------
EPS Actual0.480.530.480.600.710.730.770.820.871.101.121.190.811.471.520.800.25-1.732.921.098.560.542.142.342.041.140.680.511.671.240.390.02-0.46-0.91-0.33-0.80-1.16-0.23-0.43-0.31-38.71-11.145.51-0.940.15-0.12-0.02-0.07-0.40-0.53-0.21-0.47-0.42-0.25-0.41-0.09-0.22
Surprise-----------2.61%-22.22%-54.75%-33.48%35.71%-32.20%-69.14%----------------------------------------
Timing----------After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market-After-hours--After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours------

Key Statistics & Ratios

Market Cap250.81M
Enterprise Value274.25M
Trailing P/E0.00
Forward P/E714.29
Price / Sales7.28
Price / Book4.05
EPS-0.70
Book Value6.32
Revenue (TTM)34.45M
Gross Profit (TTM)18.38M
EBITDA-5.48M
Profit Margin-27.96%
Operating Margin-3.65%
Return on Equity-14.20%
Return on Assets-3.51%
Shares Outstanding9.95M
Shares Float8.10M
Beta0.63
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
1.42Jul 13, 2018
20171×
2.00Jul 13, 2017
20161×
1.85Jul 7, 2016
20151×
1.60Jul 6, 2015
20141×
1.35Jul 2, 2014
20131×
1.10Jul 2, 2013